Genome-wide association studies suggest the existence of a genetic component in the development of BPH, showing that some single nucleotide polymorphisms reveal a correlation with BPH and serum levels of PSA [504,505,506]. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.